You are here

Industry News

Advamed Smart Brief

April 23, 2018
Johnson & Johnson is looking to expand its vision portfolio beyond the contact lenses market, eyeing acquisitions, various st -More
April 23, 2018
Fresenius Medical Care sold its majority shareholding in Sound Inpatient Physicians Holdings to an investment consortium for  -More
April 23, 2018
A consortium of Chinese investors, including medical equipment maker Wandong and home medical equipment manufacturer Yuyue, h -More
April 23, 2018
A round of equity financing involving 13 unnamed sources has pulled in $2.9 million for South Orange, N.J.-based Nephros, an  -More
April 23, 2018
A mixed round of financing brought in about $1.8 million for Irish medtech company Kite Medical, a spinout of the NUI Galway  -More
April 23, 2018
Real-world data from a study in JACC: Cardiovascular Interventions showed the use of Neovasc's Reducer balloon-expandable ste -More
April 23, 2018
Angel Medical Systems secured premarket approval from the FDA for its AngelMed Guardian system, an implantable cardiac monito -More
April 23, 2018
The House Energy and Commerce Committee is seeking comments from stakeholders on how medical devices, especially legacy produ -More
April 23, 2018
Varian's Calypso anchored beacon transponder device, which is designed for tumor movement detection, was granted 510(k) clear -More
April 23, 2018
Qiagen has obtained approval from the FDA for its PartoSure noninvasive strip test, which is designed to measure risk of spon -More

Industry News

Helius Medical Technologies, Inc.
NEWTOWN, PA.,  April 11, 2018 - Helius Medical Technologies, Inc. (“Helius” or the “Company”) today announced the pricing of an underwritten public offering of 2,141,900 shares of its Class A common stock and warrants to purchase 2,141,900 shares of its Class A common stock at a public offering price of US$7.47 per share and accompanying warrant, before underwriting discounts and commissions.  The net proceeds to the Company from this offering, after deducting the underwriting discounts,...
PR Newswire
California-based Myoscience, Inc. announced today that it received 510k clearance from the US FDA for Smart Tip with Nerve Stim, the latest innovative tip for Myoscience’s iovera° platform technology. With the FDA clearance for Smart Tip with Nerve Stim, physicians will be able to stimulate a nerve in advance of delivering iovera° cold therapy to the treatment area, reducing patient treatment times. Additionally, the use of Smart Tip with Nerve Stim enables physicians using iovera° to access...
Media Planet
It sometimes strikes without warning. People of any age, race, ethnicity and gender are at risk. In fact, it is the leading killer of both men and women in America. It is heart disease, and each year it claims the lives of over 600,000 Americans, accounting for one-quarter of all deaths in the United States. 
Boston Scientific
Boston Scientific commends the efforts of key champions in the U.S. House and Senate for their successful efforts to suspend the medical device tax, allowing the device industry to reinvest in work to benefit patients.
Sysmex America
LINCOLNSHIRE, ILL. – Nov. 8, 2017 – Sysmex America announced today that its Sysmex XW-100 received clearance from the U.S. Food and Drug Administration (FDA)—making it the first Clinical Laboratory Improvement Amendments (CLIA)-waived, complete blood count (CBC) system. Once prepared for each day’s use, the XW-100 will allow health care professionals to provide patients with blood test results in as few as three minutes.